Refine
Year of publication
Document Type
- Article (27)
- Conference Proceeding (4)
Language
- English (31)
Has Fulltext
- yes (31)
Is part of the Bibliography
- no (31) (remove)
Keywords
- glioblastoma (4)
- glioma (3)
- meningioma (3)
- Hemorrhage (2)
- Prognosis (2)
- dexamethasone (2)
- Aneurysms (1)
- Anticoagulant therapy (1)
- BRAF (1)
- BRAF V600E (1)
- Biomarker (1)
- Blood (1)
- Blood groups (1)
- Brain tumor surgery (1)
- DNA methylation (1)
- Death rates (1)
- Epidermal growth factor receptor (1)
- Epileptic seizures (1)
- Frontobasal (1)
- Glioblastoma (1)
- Glioma (1)
- Hydrocephalus (1)
- IDH mutation (1)
- Infarction (1)
- KIF (1)
- KIF11 (1)
- KOOS IV (1)
- KPS (1)
- Left hemisphere (1)
- Lesions (1)
- MRI (1)
- MRI patterns of gliomas (1)
- Malignant meningioma (1)
- Mammalian target of rapamycin (1)
- Medical risk factors (1)
- Meningioma (1)
- Multivariate analysis (1)
- NCH93 (1)
- NK-92 (1)
- Neuropilin (1)
- Nimotuzumab (1)
- Olfactory groove meningioma (1)
- Oncology (1)
- PD-1 (1)
- PD-L1 (1)
- PXA (1)
- Peritumoural oedema (1)
- Quality of life (1)
- Resection (1)
- Return to work (1)
- SAH (1)
- SF-36 (1)
- SKALE score (1)
- Signs and symptoms (1)
- Skull base (1)
- TTFields (1)
- Targeted therapy (1)
- VEGF (1)
- VEGF receptors (1)
- acute kidney injury (1)
- adoptive cancer immunotherapy (1)
- anaemia (1)
- aneurysm (1)
- brain cancer (1)
- brain metastases (1)
- chimeric antigen receptor (1)
- complications (1)
- corticosteroids (1)
- dabrafenib (1)
- elderly (1)
- facial nerve functional outcome (1)
- glioma microenvironment (1)
- hearing nerve (1)
- hydrocephalus (1)
- hypoxia (1)
- immune infiltration (1)
- intraventricular chemotherapy (1)
- kinesin (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- long-term outcome (1)
- malignant glioma (1)
- metabolism (1)
- microsurgical treatment (1)
- mitochondria (1)
- natural killer cells (1)
- neurocritical care (1)
- non-aneurysmal (1)
- non-perimesencephalic (1)
- outcome (1)
- patterns of progression (1)
- perimesencephalic (1)
- perioperative ischemia (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- pleomorphic xanthoastrocytoma (1)
- prepontine (1)
- red blood cells (1)
- regorafenib (1)
- regorafenib csf concentration (1)
- short-term (1)
- subarachnoid hemorrhage (1)
- survival (1)
- transfusion (1)
- translational investigation (1)
- tumor-infiltrating lymphocytes (1)
- ventriculoperitoneal shunt (1)
- vestibular schwannoma (1)
Institute
- Medizin (31)
- Georg-Speyer-Haus (1)
Kinesins play an important role in many physiological functions including intracellular vesicle transport and mitosis. The emerging role of kinesins in different cancers led us to investigate the expression and functional role of kinesins in meningioma. Therefore, we re-analyzed our previous microarray dataset of benign, atypical, and anaplastic meningiomas (n = 62) and got evidence for differential expression of five kinesins (KIFC1, KIF4A, KIF11, KIF14 and KIF20A). Further validation in an extended study sample (n = 208) revealed a significant upregulation of these genes in WHO°I to °III meningiomas (WHO°I n = 61, WHO°II n = 88, and WHO°III n = 59), which was most pronounced in clinically more aggressive tumors of the same WHO grade. Immunohistochemical staining confirmed a WHO grade-associated upregulated protein expression in meningioma tissues. Furthermore, high mRNA expression levels of KIFC1, KIF11, KIF14 and KIF20A were associated with shorter progression-free survival. On a functional level, knockdown of kinesins in Ben-Men-1 cells and in the newly established anaplastic meningioma cell line NCH93 resulted in a significantly inhibited tumor cell proliferation upon siRNA-mediated downregulation of KIF11 in both cell lines by up to 95% and 71%, respectively. Taken together, in this study we were able to identify the prognostic and functional role of several kinesin family members of which KIF11 exhibits the most promising properties as a novel prognostic marker and therapeutic target, which may offer new treatment options for aggressive meningiomas.